Risk of nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid and updated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment
Isabelle Gauthier, Chad Arthur Macleod, Paul Sathiadoss, Trevor A. McGrath, Vimoj Nair, Nicola Schieda
Topics & Concepts
MedicineNephrogenic systemic fibrosisRenal functionGadoxetic acidInternal medicineHepatologyDialysisIncidence (geometry)CreatinineKidney diseaseGastroenterologyUrologyMagnetic resonance imagingRadiologyGadolinium DTPAOpticsPhysicsLanthanide and Transition Metal ComplexesAcute Kidney Injury ResearchElectron Spin Resonance Studies